Ultraschall Med 2015; 36(04): 355-361
DOI: 10.1055/s-0034-1366563
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Fusion of Magnetic Resonance Imaging and Real-Time Elastography to Visualize Prostate Cancer: A Prospective Analysis using Whole Mount Sections after Radical Prostatectomy

Fusion von Magnetresonanztomografie und Real-time-Elastografie zur Visualisierung des Prostatakarzinoms: Eine prospektive Analyse anhand von Großflächenschnitten nach radikaler Prostatektomie
M. Brock
1   Urology, Ruhr-University Bochum, Marienhospital Herne, Germany
,
F. Roghmann
1   Urology, Ruhr-University Bochum, Marienhospital Herne, Germany
,
C. Sonntag
2   Radiology, Ruhr-University Bochum, Marienhospital Herne, Germany
,
F. Sommerer
3   Pathology, Ruhr-University Bochum, Berufsgenossenschaftliche Universitätsklinik Bergmannsheil GmbH, Bochum, Germany
,
Z. Tian
4   Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada
,
B. Löppenberg
1   Urology, Ruhr-University Bochum, Marienhospital Herne, Germany
,
R. J. Palisaar
1   Urology, Ruhr-University Bochum, Marienhospital Herne, Germany
,
J. Noldus
1   Urology, Ruhr-University Bochum, Marienhospital Herne, Germany
,
J. Hanske
1   Urology, Ruhr-University Bochum, Marienhospital Herne, Germany
,
C. von Bodman
1   Urology, Ruhr-University Bochum, Marienhospital Herne, Germany
› Author Affiliations
Further Information

Publication History

25 November 2013

23 April 2014

Publication Date:
22 May 2014 (online)

Abstract

Purpose: To determine whether the fusion of multiparametric magnetic resonance imaging (MRI) with transrectal real-time elastography (RTE) improves the visualization of PCa lesions compared to MRI alone.

Materials and Methods: In a prospective setting, 45 patients with biopsy-proven PCa received prostate MRI prior to radical prostatectomy (RP). T2 and diffusion-weighted imaging (T2WI/DW-MRI) and, if applicable, dynamic contrast-enhanced sequences (T2WI/DW/DCE-MRI) were used to perform MRI/RTE fusion. The probability of PCa on MRI was graded according to the PI-RADS score for 12 different prostate sectors per patient. MRI images were fused with RTE to stratify suspicious from non-suspicious sectors. Imaging results were compared to whole mount sections using nonparametrical receiver operating characteristic curves and the area under these curves (AUC).

Results: 41 of 45 patients were eligible for final analyses. Histopathology confirmed PCa in 261 (53 %) of 492 prostate sectors. MRI alone provided an AUC of 0.62 (T2WI/DW-MRI) and 0.65 (T2WI/DW/DCE-MRI) to predict PCa and was meaningfully enhanced to 0.75 (T2WI/DW-MRI) and 0.74 (T2WI/DW/DCE-MRI) using MRI/RTE fusion. Sole MRI showed a sensitivity and specificity of 57.9 % and 61 % with the best results for ventral prostate sectors whereas RTE was superior in dorsal and apical sectors. MRI/RTE fusion improved sensitivity and specificity to 65.9 % and 75.3 %, respectively. Additional use of DCE sequences showed a sensitivity and specificity of 65 % and 55.7 % for MRI and 72.1 % and 66 % for MRI/RTE fusion.

Conclusion: MRI/RTE fusion provides improved PCa visualization by combining the strength of both imaging techniques in regard to prostate zonal anatomy and thereby might improve future biopsy-guided PCa detection.

Zusammenfassung

Ziel: Die Aussagekraft der Fusion von Magnetresonanztomografie (MRT) und transrektaler Real-time Elastografie (RTE) soll hinsichtlich der Visualisierung des Prostatakarzinoms (PCa) bewertet werden.

Material und Methode: 45 konsekutive Patienten mit vorbekanntem PCa erhielten vor radikaler Prostatektomie (RP) ein MRT. Die Bilddaten aus T2- und diffusionsgewichteten MRT (T2WI/DW-MRI) sowie kontrastmittelverstärktem MRT (T2WI/DW/DCE-MRI) wurden für eine MRT/RTE-Fusion verwendet. Die PCa-Vorhersage mittels MRT und MRT/RTE-Fusion erfolgte separat für 12 definierte Sektoren in Anlehnung an die Pi-RADS Klassifikation. Die Aussagen beider Verfahren wurde unter Verwendung von ROC-Analysen mit Großflächenschnitten nach RP verglichen.

Ergebnisse: Die Auswertung von 41 der 45 Patienten zeigte in 261 (53 %) der 492 Sektoren ein PCa. Die AUC der alleinigen MRT betrug 0,62 (T2WI/DW-MRI) bzw. 0,65 (T2WI/DW/DCE-MRI) und konnte unter Anwendung der MRT/RTE-Fusion auf 0,75 (T2WI/DW-MRI) bzw. 0,74 (T2WI/DW/DCE-MRI) erhöht werden. Die Sensitivität und Spezifität der MRT zur PCa-Vorhersage betrug 57,9 % bzw. 61 % verglichen mit 65,9 % bzw. 75,3 % der MRT/RTE-Fusion. Unter zusätzlicher Anwendung Kontrastmittel-verstärkter Bildsequenzen lag die Sensitivität und Spezifität der MRT bei 65 % und 55,7 % verglichen mit 72,1 % und 66 % unter Anwendung der MRT/RTE-Fusion.

Schlussfolgerungen: Die MRT/RTE-Fusion ermöglicht eine verbesserte PCa-Visualisierung und kombiniert die Vorteile beider bildgebenden Verfahren unter Berücksichtigung der zonalen Prostataanatomie. Die Anwendung der MRT/RTE-Fusion im Rahmen zukünftiger Biopsieprotokolle könnte eine gezielte PCa-Detektion ermöglichen.

 
  • References

  • 1 Heidenreich A, Bellmunt J, Bolla M et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. European urology 2011; 59: 61-71 PubMed PMID: 21056534. Epub 2010/11/09. eng.
  • 2 Mullerad M, Hricak H, Kuroiwa K et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. The Journal of urology 2005; 174: 2158-2163 PubMed PMID: 16280755. Epub 2005/11/11. eng.
  • 3 Pinto PA, Chung PH, Rastinehad AR et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. The Journal of urology 2011; 186: 1281-1285 PubMed PMID: 21849184. Pubmed Central PMCID: 3193933. Epub 2011/08/19. eng.
  • 4 Xu S, Kruecker J, Turkbey B et al. Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies. Comput Aided Surg 2008; 13: 255-264 PubMed PMID: 18821344. Pubmed Central PMCID: 2664902. Epub 2008/09/30. eng.
  • 5 Bax J, Cool D, Gardi L et al. Mechanically assisted 3D ultrasound guided prostate biopsy system. Med Phys 2008; 35: 5397-5410 PubMed PMID: 19175099. Epub 2009/01/30. eng.
  • 6 Hadaschik BA, Kuru TH, Tulea C et al. A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion. The Journal of urology 2011; 186: 2214-2220 PubMed PMID: 22014798. Epub 2011/10/22. eng.
  • 7 Schilling D, Kurosch M, Mager R et al. Fusion imaging in urology : Combination of MRI and TRUS for detection of prostate cancer. Der Urologe Ausg 2013; 52: 481-489 PubMed PMID: 23483269. Epub 2013/03/14. Fusionsbildgebung in der Urologie : Die Kombination von MRT und TRUS zur Detektion des Prostatakarzinoms. ger.
  • 8 Brock M, von Bodman C, Sommerer F et al. Comparison of real-time elastography with grey-scale ultrasonography for detection of organ-confined prostate cancer and extra capsular extension: a prospective analysis using whole mount sections after radical prostatectomy. BJU international 2011; 108: E217-E222 PubMed PMID: 21819532. Epub 2011/08/09. eng.
  • 9 Brock M, von Bodman C, Palisaar RJ et al. The impact of real-time elastography guiding a systematic prostate biopsy to improve cancer detection rate: a prospective study of 353 patients. The Journal of urology 2012; 187: 2039-2043 PubMed PMID: 22498211. Epub 2012/04/14. eng.
  • 10 Ganzer R, Brandtner A, Wieland WF et al. Prospective blinded comparison of real-time sonoelastography targeted versus randomised biopsy of the prostate in the primary and re-biopsy setting. World journal of urology 2012; 30: 219-223 PubMed PMID: 21519851. Epub 2011/04/27. eng.
  • 11 Pelzer AE, Heinzelbecker J, Weiss C et al. Real-time sonoelastography compared to magnetic resonance imaging using four different modalities at 3.0T in the detection of prostate cancer: Strength and weaknesses. European journal of radiology 2013; 82: 814-821 PubMed PMID: 23273821. Epub 2013/01/01. eng.
  • 12 Barentsz JO, Richenberg J, Clements R et al. ESUR prostate MR guidelines 2012. European radiology 2012; 22: 746-757 PubMed PMID: 22322308. Pubmed Central PMCID: 3297750. Epub 2012/02/11. eng.
  • 13 Cosgrove D, Piscaglia F, Bamber J et al. EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography. Part 2: Clinical Applications. Ultraschall in Med 2013; 34: 238-253
  • 14 Konig K, Scheipers U, Pesavento A et al. Initial experiences with real-time elastography guided biopsies of the prostate. The Journal of urology 2005; 174: 115-117 PubMed PMID: 15947593. eng.
  • 15 McNeal JE, Villers AA, Redwine EA et al. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer 1990; 66: 1225-1233 PubMed PMID: 2400973. Epub 1990/09/15. eng.
  • 16 Trabulsi EJ, Sackett D, Gomella LG et al. Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer. Urology 2010; 76: 1025-1033 PubMed PMID: 20719368. Epub 2010/08/20. eng.
  • 17 Mazaheri Y, Shukla-Dave A, Muellner A et al. MRI of the prostate: clinical relevance and emerging applications. J Magn Reson Imaging 2011; 33: 258-274 PubMed PMID: 21274967. Epub 2011/01/29. eng.
  • 18 Herneth AM, Guccione S, Bednarski M. Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization. European journal of radiology 2003; 45: 208-213 PubMed PMID: 12595105. Epub 2003/02/22. eng.
  • 19 Tanimoto A, Nakashima J, Kohno H et al. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 2007; 25: 146-152 PubMed PMID: 17139633. Epub 2006/12/02. eng.
  • 20 Hara N, Okuizumi M, Koike H et al. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 2005; 62: 140-147 PubMed PMID: 15389803. Epub 2004/09/25. eng.
  • 21 Seitz M, Shukla-Dave A, Bjartell A et al. Functional magnetic resonance imaging in prostate cancer. European urology 2009; 55: 801-814 PubMed PMID: 19185981. Epub 2009/02/03. eng.
  • 22 Seitz M, Scher B, Scherr M et al. Imaging procedures to diagnose prostate cancer. Der Urologe Ausg 2007; 46: W1435-W1446 quiz W47–W48. PubMed PMID: 17665166. Bildgebende Verfahren bei der Diagnose des Prostatakarzinoms.
  • 23 Salomon G, Graefen M, Heinzer H et al. The value of real-time elastography in the diagnosis of prostate cancer. Der Urologe Ausg 2009; 48: 628-636 PubMed PMID: 19300978. Epub 2009/03/21. Die Wertigkeit der Echtzeitelastographie in der Diagnostik des Prostatakarzinoms. ger.
  • 24 Aigner F, Pallwein L, Junker D et al. Value of real-time elastography targeted biopsy for prostate cancer detection in men with prostate specific antigen 1.25 ng/ml or greater and 4.00 ng/ml or less. The Journal of urology 2010; 184: 913-917 PubMed PMID: 20643432. Epub 2010/07/21. eng.
  • 25 Pallwein L, Mitterberger M, Struve P et al. Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection. European radiology 2007; 17: 2278-2285 PubMed PMID: 17342485. eng.
  • 26 Pallwein L, Mitterberger M, Struve P et al. Real-time elastography for detecting prostate cancer: preliminary experience. BJU international 2007; 100: 42-46 PubMed PMID: 17552952. eng.
  • 27 Sumura M, Shigeno K, Hyuga T et al. Initial evaluation of prostate cancer with real-time elastography based on step-section pathologic analysis after radical prostatectomy: a preliminary study. Int J Urol 2007; 14: 811-816 PubMed PMID: 17760747. eng.
  • 28 Aigner F, Pallwein L, Schocke M et al. Comparison of real-time sonoelastography with T2-weighted endorectal magnetic resonance imaging for prostate cancer detection. J Ultrasound Med 2011; 30: 643-649 PubMed PMID: 21527612. Epub 2011/04/30. eng.